To explore whether DAPK3 destabilized PBRM1 through UBE3A in renal cancer cells, we performed knockdown of DAPK3 and UBE3A alone or in combination in 786-O and ACHN cells (Fig. 4a). Here, DAPK3 is linked to renal carcinoma.